Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus
Authors:
- Anik Girard-GlobaAGAnik Girard-Globa
- André SerusclatASAndré Serusclat
- Sophie BernardSBSophie Bernard
- Pierre BondonPBPierre Bondon
- Sylvie PicardSPSylvie Picard
- François BerthezeneFBFrançois Berthezene
- Philippe MoulinPMPhilippe Moulin
- 1 June 1998
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 138 (2) , 361-366
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- Structural Organization of the HumanPON1GeneGenomics, 1996
- The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene FamilyGenomics, 1996
- A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.Journal of Clinical Investigation, 1995
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991
- Serum arylesterase (paraoxonase) activity following myocardial infarctionClinica Chimica Acta, 1989